FDA.reportPublic FDA data

Zilbrysq 32.4 MG (equivalent to zilucoplan sodium 33.2 MG) per 0.81 ML Prefilled Syringe

RxCUI
2672507
RxNorm name
Zilbrysq 32.4 MG (equivalent to zilucoplan sodium 33.2 MG) per 0.81 ML Prefilled Syringe
Display name
Zilbrysq 32.4 MG (equivalent to zilucoplan sodium 33.2 MG) per 0.81 ML Prefilled Syringe
Full name
Zilbrysq 32.4 MG (equivalent to zilucoplan sodium 33.2 MG) per 0.81 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZILBRYSQZILUCOPLANUCB, Inc.9f1d53d6-e495-4a3a-8bb9-680a15d250342026-02-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2672507

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9f1d53d6-e495-4a3a-8bb9-680a15d25034ZILBRYSQ 32.4 MG in 0.81 ML Prefilled Syringe [PSN] · 0.81 ML zilucoplan 40 MG/ML Prefilled Syringe [Zilbrysq] [SBD] · Zilbrysq 32.4 MG (equivalent to zilucoplan sodium 33.2 MG) per 0.81 ML Prefilled Syringe [SY]313These highlights do not include all the information needed to use ZILBRYSQ safely and effectively. See full prescribing information for ZILBRYSQ. ZILBRYSQ (zilucoplan) injection, for subcutaneous use Initial U.S. Approval: 202320260203